US Patent Issued to SHIFTBIO on May 13 for "Recombinant plasma membrane-based vesicle, for treating cancer" (South Korean Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,978, issued on May 13, was assigned to SHIFTBIO INC. (Seoul, South Korea).

"Recombinant plasma membrane-based vesicle, for treating cancer" was invented by Gi-Beom Kim (Seoul, South Korea), Yoo Soo Yang (Seoul, South Korea), In-San Kim (Seoul, South Korea) and Gihoon Nam (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a recombinant plasma membrane-based vesicle, and more specifically to a recombinant plasma membrane-based vesicle comprising a VSV-G mutated protein in which histidine, the 162nd amino acid, has been substituted with arginine, and a pharmaceutical composition for treating cancer compr...